Intelligenome Us

Intelligenome develops a breakthrough CRISPR technology platform for decentralized diagnostics. This platform delivers ultra-sensitive and rapid test results for accurate pathogen detection. The technology is applied across areas including Tuberculosis, NTM, and Oncology.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

Intelligenome develops a breakthrough CRISPR technology platform for decentralized diagnostics at the point-of-care. This platform provides ultra-sensitive, rapid test results for accurate pathogen detection, including Tuberculosis and NTM. The technology also quantitatively monitors treatment response across various applications like infectious disease and oncology.